We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNDT
851
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $602K | ﹤0.01% |
26,162
+11,710
| +81% | +$180K |
|
|
RDUS
852
DELISTED
Radius Health, Inc.
RDUS
| $602K | ﹤0.01% |
33,737
| – | – |
|
853
Check Point Software Technologies
CHKP
$13.1B
| $601K | ﹤0.01% |
4,501
+3,659
| +435% | +$447K |
|
|
BWIN
854
Baldwin Insurance Group
BWIN
$2.86B
| $600K | ﹤0.01% |
20,032
+32
| +0.2% | +$926 |
|
|
CTLT
855
DELISTED
CATALENT, INC.
CTLT
| $597K | ﹤0.01% |
5,741
+5,242
| +1,051% | +$508K |
|
856
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $596K | ﹤0.01% |
5,710
| – | – |
|
857
Tapestry
TPR
$32.8B
| $596K | ﹤0.01% |
19,048
+3,510
| +23% | +$88.9K |
|
858
Fastenal
FAST
$59.5B
| $593K | ﹤0.01% |
24,342
+308
| +1% | +$7.25K |
|
859
ROBO Global Robotics & Automation Index ETF
ROBO
$2.11B
| $589K | ﹤0.01% |
9,685
| – | – |
|
860
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
| $588K | ﹤0.01% |
13,030
+11,099
| +575% | +$504K |
|
|
ATIP
861
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $586K | ﹤0.01% |
+1,093
| New | +$551K |
|
862
Watts Water Technologies
WTS
$13.1B
| $582K | ﹤0.01% |
4,790
+3,119
| +187% | +$357K |
|
|
AOD
863
abrdn Total Dynamic Dividend Fund
AOD
$1.12B
| $581K | ﹤0.01% |
65,699
-8,325
| -11% | -$69.1K |
|
864
Ollie's Bargain Outlet
OLLI
$4.94B
| $576K | ﹤0.01% |
7,046
-1,482
| -17% | -$130K |
|
|
PE
865
DELISTED
PARSLEY ENERGY INC
PE
| $576K | ﹤0.01% |
40,645
+1,126
| +3% | +$13.4K |
|
866
Amphenol
APH
$209B
| $575K | ﹤0.01% |
17,608
+14,492
| +465% | +$445K |
|
867
Royce Value Trust
RVT
$2.3B
| $574K | ﹤0.01% |
35,597
-22,505
| -39% | -$330K |
|
868
XPeng
XPEV
$11.6B
| $572K | ﹤0.01% |
13,370
+12,920
| +2,871% | +$475K |
|
|
EMD
869
Western Asset Emerging Markets Debt Fund
EMD
$616M
| $571K | ﹤0.01% |
41,081
-3,579
| -8% | -$47.1K |
|
870
Idacorp
IDA
$8.2B
| $571K | ﹤0.01% |
5,950
| – | – |
|
871
Equitable Holdings
EQH
$14.1B
| $567K | ﹤0.01% |
22,178
+1,145
| +5% | +$26.8K |
|
872
Li Auto
LI
$12.7B
| $565K | ﹤0.01% |
19,600
+12,318
| +169% | +$338K |
|
873
American Airlines Group
AAL
$10.6B
| $562K | ﹤0.01% |
35,672
+17,805
| +100% | +$247K |
|
874
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.37B
| $562K | ﹤0.01% |
11,200
+2,954
| +36% | +$148K |
|
875
Ultragenyx Pharmaceutical
RARE
$2.55B
| $560K | ﹤0.01% |
4,054
+1,885
| +87% | +$224K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.